| 2021/02/05 15:34:46 | |
|---|---|
| Price | |
| 77.5596 CHF | |
| Difference | 5.72% (4.19) |
General attributes
| ISIN | US28176E1082 |
| Symbol | EW |
| Exchange | London Stock Exchange |
| Currency | CHF |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 50,482 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - |
| Open | 77.5596 CHF |
| High | 77.5596 CHF |
| Low | 77.5596 CHF |
| Close (prev. day) | 73.3654 CHF |
| VWAP | 77.55964 CHF |
| Volume (pcs) | 15 |
| Trading volume | 1,163.39 |
| Number of trades | 1 |
| Last size | 15 |
Futures and Options
| Related Futures | - |
| Related Options | - |
PDF Downloads
| Company report: EDWARDS LIFESCIENCES CORP |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2023/10/27 |
|
Global Equity Ratings |
|
| 2023/09/29 |
|
Global Equity Ratings |
|
| 2023/09/08 |
|
Global Equity Ratings |
|
| 2023/08/22 |
|
Global Equity Ratings |
|
| 2023/08/17 |
|
Global Equity Ratings |
|
| 2021/02/05 15:34:46 | |
|---|---|
| Price | |
| 77.5596 CHF | |
| Difference | 5.72% (4.19) |
General attributes
| ISIN | US28176E1082 |
| Symbol | EW |
| Exchange | London Stock Exchange |
| Currency | CHF |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 50,482 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - |
| Open | 77.5596 CHF |
| High | 77.5596 CHF |
| Low | 77.5596 CHF |
| Close (prev. day) | 73.3654 CHF |
| VWAP | 77.55964 CHF |
| Volume (pcs) | 15 |
| Trading volume | 1,163.39 |
| Number of trades | 1 |
| Last size | 15 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | - | - | - |
| Perf (abs.) | - | - | - |
| Beta | 1.10 | 0.94 | 1.00 |
| Volatility | - | - | 2.98 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 84.2500 CHF (170) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 84.2500 CHF (85) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 84.2500 CHF (1,392) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 84.2500 CHF (729) |
| YTD High | date | 84.2500 CHF (2023/05/24) |
| YTD Low | date | 84.2500 CHF (2023/05/24) |
| 52 Weeks High | date | 84.2500 CHF (2023/05/24) |
| 52 Weeks Low | date | 84.2500 CHF (2023/05/24) |
All listings for EDWARDS LIFESCIENCES CORP
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Xetra | 2024/04/15 | 17:35 | 85.41 EUR | 0.03 | 7 |
| Vienna Stock Exchange | 2024/04/15 | 17:32 | 85.44 EUR | 0.00 | 2 |
| Tradegate | 2024/04/15 | 22:26 | 83.96 EUR | 0.15 | 18 |
| Stuttgart | 2024/04/15 | 20:32 | 84.01 EUR | 0.00 | 5 |
| SIX Swiss Exchange | 2019/06/27 | 17:35 | 60.60 CHF | 0.00 | 1 |
| NYSE | 2024/04/15 | 22:00 | 89.20 USD | 258.33 | 35,375 |
| Munich | 2024/04/16 | 08:04 | 84.29 EUR | 0.00 | 1 |
| London Stock Exchange | 2021/02/05 | 15:34 | 77.5596 CHF | 0.00 | 1 |
| Frankfurt | 2024/04/16 | 08:00 | 84.31 EUR | 0.00 | 1 |
| Euronext Milan MTF Trading After Hours | 2024/02/12 | 19:23 | 80.30 EUR | 0.01 | 1 |
| Euronext Milan MTF Global Equity Market | 2024/04/15 | 17:44 | 85.44 EUR | 0.00 | 1 |
| Duesseldorf | 2024/04/16 | 08:10 | 83.45 EUR | 0.00 | 1 |
| Berlin | 2024/04/16 | 08:08 | 83.44 EUR | 0.00 | 1 |
| BX Swiss | 2024/04/05 | 18:00 | 83.181 CHF | 0.00 | 1 |
Company Logo
Contact Details
| EDWARDS LIFESCIENCES CORP. |
| - - |
| 1 Edwards Way - 92614 Irvine |
| Telefon: +1-949-250-2500 |
| Fax: + |
| E-mail: customerservice_us@edwards.com |
PDF Downloads
| Company report: EDWARDS LIFESCIENCES CORP | |
Company Profile
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA. |
Members of Management Board
| Michael Mussallem | Chairman of Board of Directors |
| Nicholas Valeriani | Member of Board of Directors |
| Kieran Gallahue | Member of Board of Directors |
| Leslie Heisz | Member of Board of Directors |
| Martha Marsh | Member of Board of Directors |
| Paul LaViolette | Member of Board of Directors |
| Ramona Sequeira | Member of Board of Directors |
| Steven Loranger | Member of Board of Directors |
| Michael A. Mussallem | Chairman of Managing Board |
| Arnold A. Pinkston | Member of Executive Committee |
| Bernard J. Zovighian | Member of Executive Committee |
| Christine Z. McCauley | Member of Executive Committee |
| Daveen Chopra | Member of Executive Committee |
| Dirksen J. Lehman | Member of Executive Committee |
| Donald E. Bobo, Jr. | Member of Executive Committee |
| Gary I. Sorsher | Member of Executive Committee |
| Humin Wang | Member of Executive Committee |
| Jean-Luc Lemercier | Member of Executive Committee |
| Joseph Nuzzolese | Member of Executive Committee |
| Katie Szyman | Member of Executive Committee |
| Larry L. Wood | Member of Executive Committee |
| Scott B. Ullem | Member of Executive Committee |
| Todd J. Brinton | Member of Executive Committee |